D.Western Therapeutics Institute, Inc. (4576) Other
Market cap
¥4.9B
P/E ratio
-6.2x
De Western Therapeutics Institute develops protein kinase inhibitor drugs for eye diseases and licenses them to pharmaceutical companies for commercialization.
| 2011/12 | 2012/12 | 2013/12 | 2014/12 | 2015/12 | 2016/12 | 2017/12 | 2018/12 | 2019/12 | 2020/12 | 2021/12 | 2022/12 | 2023/12 | 2024/12 | 2025/12 | |
| Return on Assets | - | - | - | - | -3 | -2.6 | -8.3 | -8 | 6.6 | -5.3 | -1.8 | -7.4 | -13.8 | -27.9 | -7.3 |
| Return on equity (%) | - | - | - | ||||||||||||
| Employees | 18 | 14 | 13 | 13 | 15 | 16 | 15 | 17 | 17 | 15 | 19 | 20 | 21 | 21 | 19 |